Hualan Biological Engineering, Inc. (002007.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 12.78

From 52W high−24.34%

Volume7.93M

Market capCNY 23.44B

P/E (TTM)24.9x

P/S (TTM)5.3x

Div yield7.73%

Key dataSep 18, 2026

Open

CNY 12.78

From 52W high

−24.34%

Volume

7.93M

Market cap

CNY 23.44B

ValuationView details →

P/E (Fwd)

27.5x

EV/EBITDA

16.3x

P/E (TTM)

24.9x

RSI (14)

46.9

MomentumView details →

1D Return

−2.51%

YTD Return

−14.54%

ValuationView details →

P/E (Fwd)

27.5x

P/E (TTM)

24.9x

EV/EBITDA

16.3x

EV/Sales

5.5x

P/S (TTM)

5.3x

P/B (TTM)

2.2x

ProfitabilityView details →

Gross Margin

56.52%

Net Margin

19.10%

EBITDA Margin

33.62%

ROE (TTM)

7.32%

ROA (TTM)

5.70%

Asset Turnover

0.30x

GrowthView details →

Revenue YoY

+0.67%

EPS YoY

−24.74%

FCF YoY

+66.39%

Revenue CAGR 3Y

+0.57%

EPS CAGR 3Y

−4.41%

EBITDA YoY

—

MomentumView details →

1D Return

−2.51%

YTD Return

−14.54%

1Y Return

−20.28%

RSI (14)

46.9

vs 50D SMA

−1.81%

vs 200D SMA

−9.46%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

6.57x

Quick Ratio

4.65x

Div Yield

7.73%

Div Rate

CNY 1.00

Div Growth 1Y

+133.33%

EarningsView details →

EPS (Actual)

CNY 0.08

EPS Surprise

−27.25%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.13

Avg Surprise (4Q)

−27.25%

Rev Surprise

−6.92%

Financials snapshotView financials →

Revenue (TTM)

4.49B

Net Income (TTM)

857.61M

Op. CF (TTM)

857.39M

Next earningsNov 2, 2026 →

Latest newsMore news →

Hualan Biological Engineering announced its interim dividend plan for the first half of 2026, proposing to distribute a cash dividend of 2 CNY (tax inclusive) per 10 shares to all shareholders, totaling approximately 365 million CNY.12d ago

Hualan Biological Vaccine Co., Ltd. reduced its registered capital from 601.0275 million yuan to 565.028 million yuan, a decrease of about 6%, and changed its legal representative from An Kang to An Wenjue.14d ago

Similar companies

航发控制000738.SZ 丽珠集团000513.SZ 尚太科技001301.SZ 广电运通002152.SZ 洛轴股份301699.SZ 晶澳科技002459.SZ Find similar companies →

Latest newsMore news →

Hualan Biological Engineering announced its interim dividend plan for the first half of 2026, proposing to distribute a cash dividend of 2 CNY (tax inclusive) per 10 shares to all shareholders, totaling approximately 365 million CNY.12d ago Hualan Biological Vaccine Co., Ltd. reduced its registered capital from 601.0275 million yuan to 565.028 million yuan, a decrease of about 6%, and changed its legal representative from An Kang to An Wenjue.14d ago